sq-11725 has been researched along with Hypertension, Pulmonary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chan, KC; Das, BB | 1 |
Fujii, Y; Inagaki, T; Kuwahira, I; Nagai, H; Nara, A; Ogura, S; Pearson, JT; Schwenke, DO; Shimosawa, T; Shirai, M; Tsuchimochi, H; Uemura, K; Umetani, K; Yoshida, K | 1 |
2 other study(ies) available for sq-11725 and Hypertension, Pulmonary
Article | Year |
---|---|
Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome.
Topics: Angiography; Child; Echocardiography; Electrocardiography; Genetic Testing; Humans; Hypertension, Pulmonary; Long QT Syndrome; Male; Nadolol; Phenylpropionates; Pyridazines; Sildenafil Citrate; Syncope; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed | 2020 |
β2-Adrenergic receptor-dependent attenuation of hypoxic pulmonary vasoconstriction prevents progression of pulmonary arterial hypertension in intermittent hypoxic rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blood Pressure; Class Ia Phosphatidylinositol 3-Kinase; Disease Models, Animal; Disease Progression; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Nadolol; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Time Factors; Vasoconstriction | 2014 |